Bipolar II or unipolar depression: pharmacologic considerations
- PMID: 15515295
- DOI: 10.1111/j.1744-6163.2004.tb00008.x
Bipolar II or unipolar depression: pharmacologic considerations
Similar articles
-
Antidepressant treatment practice in the face of STAR*D and STEP-BD.Bipolar Disord. 2008 Dec;10(8):973-4. doi: 10.1111/j.1399-5618.2008.00631.x. Bipolar Disord. 2008. PMID: 19594512 No abstract available.
-
Predictors of efficacy in lithium augmentation for treatment-resistant depression.J Affect Disord. 2010 Sep;125(1-3):165-8. doi: 10.1016/j.jad.2009.12.025. Epub 2010 Jan 20. J Affect Disord. 2010. PMID: 20089312
-
[Treating mentally ill patients in ambulatory care].Pflege Z. 2012 Oct;65(10):630-1. Pflege Z. 2012. PMID: 23098037 German. No abstract available.
-
Bipolar II disorder: current and future treatment options.Ann Clin Psychiatry. 2006 Oct-Dec;18(4):259-66. doi: 10.1080/10401230600948480. Ann Clin Psychiatry. 2006. PMID: 17162626 Review.
-
Drugs for depression and bipolar disorder.Treat Guidel Med Lett. 2010 May;8(93):35-42. Treat Guidel Med Lett. 2010. PMID: 20414177 Review. No abstract available.
Cited by
-
Protective Effects of Curcuma longa L. on Corticosterone-Induced Neurotoxicity and Anti-Depression-Like Behavior: Involvement of NMDA and 5-HT7A Receptors.J Microbiol Biotechnol. 2025 Aug 5;35:e2506005. doi: 10.4014/jmb.2506.06005. J Microbiol Biotechnol. 2025. PMID: 40774823 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical